Status:
COMPLETED
A Pilot Study to Evaluate the Effectiveness of Ultrasound Guided Looped Thread Carpal Tunnel Release
Lead Sponsor:
University of Alberta
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Carpal tunnel syndrome occurs when a nerve gets pinched as it passes through a confined tunnel within the wrist and hand. It is the most commonly pinched nerve and often results in disabling hand numb...
Detailed Description
Objectives: to evaluate the effectiveness and safety of a minimally invasive ultrasound-guided looped thread technique of carpal tunnel release Background: Carpal tunnel syndrome (CTS) is the most co...
Eligibility Criteria
Inclusion
- \>18 years of age
- symptoms (hand numbness, tingling, weakness or pain; symptom aggravation with repetitive or sustained gripping; nocturnal symptom exacerbation) and signs (hand sensory disturbance or weakness; positive median nerve Tinel's sign or Phalen's test) compatible with carpal tunnel syndrome
- symptom duration \>3 months refractory to conservative treatment (i.e. wrist splints, activity modification, NSAID, +/- intracarpal tunnel corticosteroid injection)
- nerve conduction study abnormalities compatible with moderate to severe median neuropathy at the carpal tunnel (motor and sensory conduction slowing across the carpal tunnel +/- evidence of axonal loss)
- signed informed consent
Exclusion
- ultrasound identifies a bifid median nerve or persistent median artery at the carpal tunnel inlet
- Clinical or electrophysiologic evidence of a neurologic disorder of the upper extremity besides carpal tunnel syndrome (i.e. proximal median neuropathy; ulnar or radial neuropathy, brachial plexopathy, cervical radiculopathy or generalized polyneuropathy)
- Inability to understand the informed consent or the Boston Carpal Tunnel Questionnaire
- Coagulopathy or anticoagulation that cannot be stopped for the carpal tunnel release procedure
- Local anesthetic allergy
- systemic infection or a local infection at the procedure site
Key Trial Info
Start Date :
May 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03476486
Start Date
May 20 2016
End Date
January 20 2018
Last Update
May 9 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.